2014
DOI: 10.1016/j.bioorg.2013.10.002
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of new ibuprofen derivatives with their in silico and in vitro cyclooxygenase-2 inhibitions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
6
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 22 publications
(7 citation statements)
references
References 59 publications
0
6
0
Order By: Relevance
“…Previously, Hizliates et al, performed an in-silico and in-vitro molecular docking analysis of ligands derived from Ibuprofen for the inhibition of COX-2. However, they did not perform in-silico analysis as thoroughly as done in this study, such as testing for drug-likeliness and ADMET properties 25 . Bitten court et al, have also reported a similar study in which they present a comparison of the properties of ibuprofen to that of two benzoyl propionic acid derivatives.…”
Section: Fig 1: Molecular Structure Of the (2s) -2-[4-(2-oxo-2 5-dimentioning
confidence: 99%
“…Previously, Hizliates et al, performed an in-silico and in-vitro molecular docking analysis of ligands derived from Ibuprofen for the inhibition of COX-2. However, they did not perform in-silico analysis as thoroughly as done in this study, such as testing for drug-likeliness and ADMET properties 25 . Bitten court et al, have also reported a similar study in which they present a comparison of the properties of ibuprofen to that of two benzoyl propionic acid derivatives.…”
Section: Fig 1: Molecular Structure Of the (2s) -2-[4-(2-oxo-2 5-dimentioning
confidence: 99%
“…Its 5-hour reaction mixture has been re luxed. The solids gained by iltration and recrystallized by ethanol forward to cooling, The percent of yield, physical properties and RF values present in the Table 2 (Gundogdu-Hizliates et al, 2014).…”
Section: Synthesis Of the Compound(e)-n'-benzylidene-2-(4-isobutylphementioning
confidence: 99%
“…Another example of groups showing valuable COX‐2 inhibitory potential is acyl hydrazone sulfonamide and its derivatives containing acyl sulfonamide [8] . Among the newly published research on selective COX‐2 inhibitors, N ‐acyl hydrazones, as a new class of anti‐inflammatory compounds, have shown great promise in terms of selectivity in COX‐2 binding and anti‐inflammatory activity [9–12] . It is also known that the methyl sulfonyl group enhances selective COX‐2 inhibition [13–20] …”
Section: Introductionmentioning
confidence: 99%